FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000862661> ?p ?o ?g. }

• W2000862661 endingPage "974" @default.
• W2000862661 startingPage "968" @default.
• W2000862661 abstract "Elevations in cancer treatment-induced circulating inflammatory cytokines may be partially responsible for the development of significant symptom burden (e.g., pain, fatigue, distress, disturbed sleep) during concurrent chemoradiation therapy (CXRT). Sixty-two patients undergoing CXRT for locally advanced non-small cell lung cancer (NSCLC) reported symptoms weekly for 15 weeks via the M. D. Anderson Symptom Inventory (MDASI). Serum inflammatory cytokines were assessed weekly during therapy via enzyme-linked immunosorbent assay. Dynamic changes in cytokines and associated symptom profiles were estimated using mixed-effect models. MDASI symptom severity increased gradually as CXRT dose accumulated and peaked at week 8. Serum concentrations of interleukin (IL)-6, IL-10, and serum soluble receptor 1 for tumor necrosis factor (sTNF-R1) increased significantly by week 8 (all p < .05). During CXRT, controlled for age, sex, race, body mass index, cancer recurrence, previous treatment status, total radiotherapy dose, and CXRT delivery technique, an increase in sTNF-R1 was significantly related to an increase in the mean score for all 15 MDASI symptoms (estimate, 1.74; SE, 0.69; p < .05) and to a larger radiation dose to normal lung volume (estimate, 1.77; SE, 0.71; p < .01); an increase in serum IL-6 was significantly related to increased mean severity for the five most severe symptoms (pain, fatigue, disturbed sleep, lack of appetite, sore throat) (estimate, 0.32; SE, 0.16; p < .05). These results suggest a role for over-expressed pro-inflammatory cytokines in significant worsening of symptoms in NSCLC patients undergoing CXRT, and warrant further study to identify biological targets for ameliorating treatment-related symptom burden." @default.
• W2000862661 created "2016-06-24" @default.
• W2000862661 creator A5006430883 @default.
• W2000862661 creator A5015248772 @default.
• W2000862661 creator A5023135321 @default.
• W2000862661 creator A5031788907 @default.
• W2000862661 creator A5032101004 @default.
• W2000862661 creator A5047095924 @default.
• W2000862661 creator A5051140384 @default.
• W2000862661 creator A5086483620 @default.
• W2000862661 date "2010-08-01" @default.
• W2000862661 modified "2023-10-17" @default.
• W2000862661 title "Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy" @default.
• W2000862661 cites W1952272382 @default.
• W2000862661 cites W1965208523 @default.
• W2000862661 cites W1987561330 @default.
• W2000862661 cites W1987694020 @default.
• W2000862661 cites W1991815527 @default.
• W2000862661 cites W1992849701 @default.
• W2000862661 cites W2004028194 @default.
• W2000862661 cites W2020861040 @default.
• W2000862661 cites W2022864747 @default.
• W2000862661 cites W2023505415 @default.
• W2000862661 cites W2025959513 @default.
• W2000862661 cites W2035121795 @default.
• W2000862661 cites W2040350917 @default.
• W2000862661 cites W2042047630 @default.
• W2000862661 cites W2043945205 @default.
• W2000862661 cites W2068132070 @default.
• W2000862661 cites W2068185418 @default.
• W2000862661 cites W2071774307 @default.
• W2000862661 cites W2082130603 @default.
• W2000862661 cites W2084497339 @default.
• W2000862661 cites W2089093824 @default.
• W2000862661 cites W2090363571 @default.
• W2000862661 cites W2097597124 @default.
• W2000862661 cites W2101995865 @default.
• W2000862661 cites W2102537627 @default.
• W2000862661 cites W2109364152 @default.
• W2000862661 cites W2116208378 @default.
• W2000862661 cites W2119298887 @default.
• W2000862661 cites W2128069079 @default.
• W2000862661 cites W2128416931 @default.
• W2000862661 cites W2164859678 @default.
• W2000862661 cites W2338867329 @default.
• W2000862661 cites W1996177359 @default.
• W2000862661 doi "https://doi.org/10.1016/j.bbi.2010.03.009" @default.
• W2000862661 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2897921" @default.
• W2000862661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20353817" @default.
• W2000862661 hasPublicationYear "2010" @default.
• W2000862661 type Work @default.
• W2000862661 sameAs 2000862661 @default.
• W2000862661 citedByCount "150" @default.
• W2000862661 countsByYear W20008626612012 @default.
• W2000862661 countsByYear W20008626612013 @default.
• W2000862661 countsByYear W20008626612014 @default.
• W2000862661 countsByYear W20008626612015 @default.
• W2000862661 countsByYear W20008626612016 @default.
• W2000862661 countsByYear W20008626612017 @default.
• W2000862661 countsByYear W20008626612018 @default.
• W2000862661 countsByYear W20008626612019 @default.
• W2000862661 countsByYear W20008626612020 @default.
• W2000862661 countsByYear W20008626612021 @default.
• W2000862661 countsByYear W20008626612022 @default.
• W2000862661 countsByYear W20008626612023 @default.
• W2000862661 crossrefType "journal-article" @default.
• W2000862661 hasAuthorship W2000862661A5006430883 @default.
• W2000862661 hasAuthorship W2000862661A5015248772 @default.
• W2000862661 hasAuthorship W2000862661A5023135321 @default.
• W2000862661 hasAuthorship W2000862661A5031788907 @default.
• W2000862661 hasAuthorship W2000862661A5032101004 @default.
• W2000862661 hasAuthorship W2000862661A5047095924 @default.
• W2000862661 hasAuthorship W2000862661A5051140384 @default.
• W2000862661 hasAuthorship W2000862661A5086483620 @default.
• W2000862661 hasBestOaLocation W20008626612 @default.
• W2000862661 hasConcept C121608353 @default.
• W2000862661 hasConcept C126322002 @default.
• W2000862661 hasConcept C141071460 @default.
• W2000862661 hasConcept C143998085 @default.
• W2000862661 hasConcept C164027704 @default.
• W2000862661 hasConcept C17991360 @default.
• W2000862661 hasConcept C2776256026 @default.
• W2000862661 hasConcept C2776914184 @default.
• W2000862661 hasConcept C2777870961 @default.
• W2000862661 hasConcept C2780221984 @default.
• W2000862661 hasConcept C509974204 @default.
• W2000862661 hasConcept C71924100 @default.
• W2000862661 hasConcept C90924648 @default.
• W2000862661 hasConceptScore W2000862661C121608353 @default.
• W2000862661 hasConceptScore W2000862661C126322002 @default.
• W2000862661 hasConceptScore W2000862661C141071460 @default.
• W2000862661 hasConceptScore W2000862661C143998085 @default.
• W2000862661 hasConceptScore W2000862661C164027704 @default.
• W2000862661 hasConceptScore W2000862661C17991360 @default.
• W2000862661 hasConceptScore W2000862661C2776256026 @default.
• W2000862661 hasConceptScore W2000862661C2776914184 @default.
• W2000862661 hasConceptScore W2000862661C2777870961 @default.
• W2000862661 hasConceptScore W2000862661C2780221984 @default.

• next